Bugworks

Linked-in

2023

CARB-X Continuing grant for Phase-1 Clinical Trial

2022

GARDP grant to support a part of Phase-1 Clinical Trial

2021

CARB-X Continuing grant for preclinical development

2019

CARB-X Continuing grant for preclinical development

2018

Combating resistant superbugs by understanding the molecular determinants of target site penetration and binding

2017

Bugworks gets CARB-X funding

2016

DBT-BIPP Continuing grant for “Structure based strategy to ameliorate antibiotic efflux and enhance efficacy”

2014

DBT-BIPP grant for “Structure based strategy to ameliorate antibiotic efflux and enhance efficacy”

2014

BIG Grant: Reverse MOA For deciphering the target for anti-bacterial compounds emerging from phenotypic screens

2014

Discovery of novel combinations for tuberculosis through NIH contract services, USA

to top